Recursion Pharmaceuticals, Inc.

JANUS HENDERSON GROUP PLC RXRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

138,209

Value ($000)

565

Weight

0.0%

2022 Q2 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	565	0.0%	138,209	12/31/2025
2025 Q3	11/14/2025	674	0.0%	138,209	9/30/2025
2025 Q2	8/14/2025	555	0.0%	109,728	6/30/2025
2025 Q1	5/15/2025	638	0.0%	109,728	3/31/2025
2024 Q4	2/14/2025	565	0.0%	83,628	12/31/2024
2024 Q3	11/14/2024	552	0.0%	83,628	9/30/2024
2024 Q2	8/14/2024	626	0.0%	83,628	6/30/2024
2024 Q1	5/15/2024	621	0.0%	62,422	3/31/2024
2023 Q4	2/14/2024	614	0.0%	62,397	12/31/2023
2023 Q3	11/14/2023	478	0.0%	62,506	9/30/2023
2023 Q2	8/14/2023	466	0.0%	62,410	6/30/2023
2023 Q1	5/15/2023	143	0.0%	21,384	3/31/2023
2022 Q2	8/15/2022	83	0.0%	10,162	6/30/2022